Overview of Skin Cancers for General Practitioners

Tarek Haykal

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

AAD 2024 Insights: What's New In Nail Tumors

AAD 2024

J. Dominguez-Cherit

Year in Review: Bowen Diseases and Squamous Cell Carcinoma of the Na…

2024 Year in Review

J. Dominguez-Cherit

AAD 2024 Insights: Prevention and Active Surveillance of Keratinocyt…

Brigham and Women's Hospital Department of Dermatology

R. Hartman

EADV 2024 Insights: Dermatology in Skin of Color Patients - Challeng…

EADV 2024 Insights

N. Benmehidi

Year in Review: Actinic Keratosis

2023 Year in Review

L. Kircik

AAD 2024 Insights: Immunomodulators in Non-Melanoma Skin Cancer

AAD 2024

V. Patel

Oncolytic Viral Therapies in the Treatment of Melanoma and Other Ski…

Melanoma Research Foundation

G. In

Molecular vs. Multidisciplinary Tumour Boards in Skin Cancers

Alberto Cunquero

Year in Review: Updates in Non-Melanoma Skin Cancers

Dana-Farber Cancer Institute

K. Khaddour

EADV 2023 Insights: Treating Cancer in the Elderly: Minimally Invasi…

EADV 2023 Insights

P. Pasquali

Managing Complications of Dermatologic Surgery

Masterclasses in Dermatology

D. Siegel

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

EADV 2023 Insights

G. Hofbauer

Neoadjuvant IO: Non-Melanoma Skin Cancer

ImmunoTherapy Bridge 2023

N. Gross

We Never Looked: What Happens When Gynecologic Care Ceases After Age…

Amaris Geisler

How do you Undertake a Multidisciplinary Approach to SCC Management?

dermsquared

L. Korb Ferris

Non-Melanoma Skin Cancers

ImmunoTherapy Bridge 2023

P. A. Ascierto

ESMO 2023 Insights: "Neoadjuvant Cemiplimab for Stage II to IV CSCC …

Insights from 2023 ESMO Annual Meeting

N. Gross

Management of High Risk Squamous Cell Carcinoma

NYU Langone

M. L. Stevenson